Zobrazeno 1 - 10
of 196
pro vyhledávání: '"Tabatabaiefar M"'
Publikováno v:
Journal of Sciences, Islamic Republic of Iran; Spring2023, Vol. 34 Issue 2, p111-117, 7p
Publikováno v:
Journal of Sciences, Islamic Republic of Iran; Autumn2022, Vol. 33 Issue 4, p305-309, 5p
Autor:
Shakarami F; Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.tabatabaiefar@med.mui.ac.ir., Nouri Z, Khanahmad H, Ghazavi M, Amin Tabatabaiefar M
Publikováno v:
Journal of genetics [J Genet] 2023; Vol. 102.
Autor:
Rezaeian, F.1, Tabatabaiefar, M. A.2, Heybati, F.3, Reiisi, S.4, Parchami, Sh5, Abolhasani, M.5, Amiri, B.5, Salehi, A. R.5, Hashemzadeh-Chaleshtori, M.5 mchalesh@yahoo.com
Publikováno v:
Journal of Shahrekord University of Medical Sciences. Oct/Nov2014, Vol. 16 Issue 4, p62-70. 9p.
Publikováno v:
Iranian Journal of Public Health
Scopus-Elsevier
Iranian Journal of Public Health, Vol 46, Iss 1 (2017)
Scopus-Elsevier
Iranian Journal of Public Health, Vol 46, Iss 1 (2017)
Background: Hearing loss (HL) is the most frequent neurosensory impairment. HL is highly heterogeneous defect. This disorder affects 1 out of 500 newborns. This study aimed to determine the role of DFNB2 locus and frequency of MYO7A gene mutations in
Autor:
Zamani, M.1,2 mzamani@sina.tums.ac.ir, Tabatabaiefar, M. A.1, Mosayyebi, S.2,3, Mashaghi, A.2, Mansouri, P.4
Publikováno v:
Clinical & Experimental Dermatology. Jul2010, Vol. 35 Issue 5, p521-524. 4p. 3 Charts, 1 Graph.
Autor:
Ahmadvand, M., Noruzinia, M., Dehghani Fard, A., Mostafa Montazer zohour, Amin Tabatabaiefar, M., Soleimani, M., Kaviani, S., Abroun, S., Beiranvand, S., Saki, N.
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 8, Iss 1 (2014)
Scopus-Elsevier
International Journal of Hematology-Oncology and Stem Cell Research
Scopus-Elsevier
International Journal of Hematology-Oncology and Stem Cell Research
Background: β-thalassemia considers worldwide public health disorders. Novel fetal hemoglobin inducer agents such as thalidomide and sodium butyrate have been attended for ameliorating clinical complications of such disorders. Material and Methods:
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rasouli, H. A., Moghadam, M. M., Tabatabaiefar, M., Taslimi, F., Sheybani, K. M., Alidoosti, A., Ahmad Ameri, Fadavi, P., Aref, S.
Publikováno v:
Acta Medica Iranica, Vol 50, Iss 1 (2012)
Scopus-Elsevier
Acta Medica Iranica, Vol 50, Iss 1, Pp 43-46 (2012)
Scopus-Elsevier
Acta Medica Iranica, Vol 50, Iss 1, Pp 43-46 (2012)
The objective of this study was to determine and compare Cystatin C changes before and after radiotherapy in patients with stomach cancer who were candidate for radiotherapy. This study was conducted as a prospective cohort one. Eighteen patients wit
Autor:
Maleknejad, Shohreh1 (AUTHOR), Dalili, Setila1 (AUTHOR) setiladalili1346@yahoo.com, Sharifi, Ameneh2 (AUTHOR), Hassanzadeh Rad, Afagh1 (AUTHOR), Bayat, Reza1 (AUTHOR), Rabbani, Bahareh2 (AUTHOR), Mahdieh, Nejat3 (AUTHOR) nmahdieh@yahoo.com, Falhammar, Henrik (AUTHOR)
Publikováno v:
International Journal of Endocrinology. 8/5/2024, Vol. 2024, p1-8. 8p.